Business · 09/05/2002

Bavarian Red Cross Faces FDA Hearing on License Revocation for Whole Blood and Red Blood Cells

The FDA is holding a hearing to consider revoking the Bavarian Red Cross's U.S. license No. 1002, which allows the organization to manufacture Whole Blood and Red Blood Cells, due to non-compliance with FDA standards and regulations.